期刊文献+

产ESBLs菌株的流行现状及耐药性分析 被引量:8

Production of ESBLs strains of epidemic status and drug resistance analysis
暂未订购
导出
摘要 目的了解产ESBLs菌株的流行现状,依照新版CLSI文件指导原则对产ESBLs菌株的耐药性进行分析,为临床治疗产ESBLs菌株感染提供依据。方法收集笔者所在医院2010年8月~2011年12月临床标本中分离的大肠埃希菌和肺炎克雷伯菌,采用DL-96细菌测定系统进行检测分析。结果大肠埃希菌ESBLs检出率为64.8%,肺炎克雷伯菌ESBLs检出率为31.6%;在药敏方面,依照新版CLSI文件指导原则,产ESBLs菌株对头孢他啶、头孢吡肟、氨曲南的敏感结果不再报为耐药;产ESBLs菌株对碳青霉烯类仍具有极高的敏感率;对哌拉西林/他唑巴坦、头孢哌酮/舒巴坦、头孢西丁、阿米卡星、美满霉素的敏感性较好;对氟喹诺酮类、阿莫西林/克拉维酸、氨苄西林/舒巴坦、磺胺甲恶唑/甲氧苄啶、庆大霉素、四环素的敏感性差。结论抗菌药物的不合理应用,使产ESBLs菌株大量出现,而新版CLSI文件指导原则为临床治疗产ESBLs菌株感染,使用敏感的头孢菌素和氨曲南提供了依据,临床上应提高感染性疾病标本的送检率,依据药敏结果,科学合理使用抗生素。 Objective Understanding of ESBLs strains of epidemic situation,in accordance with the new version of the CLSI file guiding principle for the ESBLs producing strains resistant to undertake an analysis,for the clinical treatment of ESBLs strain infection. Methods The hospital in August 2010 - December 2011 were collected in clinical specimens of Escherichia coli isolated from Borrelia bacteria pneumonia and cray, using DL-96 bacterial assay system for detection and analysis. Results Escherichia coli ESBLs detection rate of 64.8%, cray Borrelia bacteria pneumonia ESBLs positive rate was 31.6%;in susceptibility,in accordance with the new version of the CLSI file guiding principle, produce ESBLs strains of ceftazidime,cefepime, ammonia song south sensitive results in longer to resistance;ESBLs strains to carbapenems still has a very high sensitivity rates; on piperacillin/tazobactam,cefoperazone/shu TAZ,cefoxitin, amikacin, minocycline sensitivity is better;the fluoroquinolones,amoxicillin/clavulanic acid,ampicillin/shu TAZ, sulfamethoxa-zole/trimethoprim,gentamicin,tetr- acycline sensitivity difference. Conclusion Unreasonable application of antibiotics,so that ESBLs strains appeared in large numbers,and a new version of the CLSI file guiding principles for clinical treatment of ESBLs strain infection,use of sensitive to cephalosporin and ammonia song south provided a basis,clinical should improve infectious disease specimen examination rate, according to drug susceptibility results,scientific and rational use of antibiotics.
作者 李丹
出处 《中国医药科学》 2012年第13期54-56,共3页 China Medicine And Pharmacy
关键词 CLSI 超广谱Β-内酰胺酶 大肠埃希菌 肺炎克雷伯菌 CLSI Extended spectrum beta-lactamses Escherichia coli Cray borrelia bacteria pneumonia
  • 相关文献

参考文献3

  • 1Clinical and Laboratory Standards Institute.Performance standards for antimicrobial susceptibility testing; twentieth informational supplement[S]. CLSI,2010: M 100-$20.
  • 2孙景勇,倪语星.Mohnarin 2008年度报告:华东地区细菌耐药监测[J].中国抗生素杂志,2010,35(7):503-507. 被引量:37
  • 3Wang H, Kelkar S, Wu W, et al.Clinical isolates of enterobacteriaceae producing extended-spectrum beta-lactamases: prevalence of CTX-M-3 at a hospital in China[J].Antimicrob Agents Chemother,2003,47 ( 2 ) : 790-793.

二级参考文献9

共引文献36

同被引文献63

  • 1陆军,高占珍,王金明.251株产ESBLs的G^-杆菌药敏分析及临床意义[J].宁夏医学杂志,2012,34(8):791-792. 被引量:2
  • 2卫生部办公厅.关于抗菌药物临床应用管理有关问题的通知[S].卫办医政发[2009]38号.
  • 3卫生部合理用药专家委员会.中国医师药师临床用药指南.重庆:重庆出版社,2009:103-105.
  • 4卫生部办公厅.关于做好全国抗菌药物临床应用专项整治活动的通知[s].卫办医政发[2011]56号.
  • 5卫生部、国家中医药管理局、总后卫生部.抗菌药物临床应用指导原则[S].卫医发[2004]285号.
  • 6中华人民共和国卫生部.抗菌药物临床应用指导原则(卫医发[20041285号)[EB/OL].(2004.8.19).(2013.2.28).http://www.mob.gov.cn/wsb/pzcjd/200804/21154.shtml.
  • 7Dandekar P K, Maglio D, Sutherland C A, et al. Pharmacokinet- ics of meropenem 0.5 and 2g every 8 hours as a 3-hour infusion [ J ]. Pharmacotherapy, 2003,23 ( 8 ) : 988-991.
  • 8陈在英,钟南山.内科学[M].7版北京:人民卫生出版社,2008:267.
  • 9YONG D, TOLEMAN M, GISKE C, et al. Characterization of a New Metallo-fllaetamase gene, blaNDM-1, and will be a erythromycin es- terase gene carried on a unique based structure in Klebsiella Pneu- moniae sequence type 14 from India [ J ]. Antimicrob Agents Che- mother, 2011,53 ( 12 ) : 2011-5054.
  • 10NORDMANN P, CUZON G, NAAS T, et al. The real threat of Kleb- siella pneumonia carbapenemase-producing bacteria [J]. Lancet In- fect Dis, 2009,9(4) :228-236.

引证文献8

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部